Pamela N. Agaba

FDA investigator

Appears on 4 documents from 2023 to 2025, mostly at sites in Florida. Most often cites general requirements (21 CFR 211.160).

4
Documents on file
5.5
Observations per 483
2023
First seen
2025
Most recent

What they cite most

From 22 observations

Activity by year

2023: 1, 2024: 1, 2025: 2

Where

Florida 2 · New Jersey 1 · South Korea 1

Is Pamela N. Agaba coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Active Cosmetics Manufacturing IncOct 31, 2025 · Orlando, Florida
483 Geri-Care Pharmaceuticals, CorpMay 5, 2025 · Lakewood, New Jersey
483 Natuzen Co.,Ltd.Nov 21, 2024 · Incheon, South Korea
483 OMEZA LLCJul 28, 2023 · Sarasota, Florida

About this profile

What does Pamela N. Agaba inspect?

Pamela N. Agaba appears on 4 documents on file covering 4 sites, mostly in Florida.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.22(d) and 21 CFR 211.84.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Pamela N. Agaba is dated Oct 31, 2025.